Katya Kowalski

The regulatory landscape for CBD in the UK can be confusing. What does the latest guidance from the Food Standards Agency (FSA) mean? Last week, in a “surprise” reversal the …

Lots of arguments get thrown around when it comes to recreational cannabis legalisation, with claims that usage goes down and mental health outcomes improve. But, what does the literature say …

First Wednesdays have launched their latest report: ‘The Social Impact of Cannabis Legalisation: How cannabis reform can shape lives, livelihoods and the law’. European cannabis reform is happening right in …

The media landscape is rapidly changing. With the continued rise of social media as a medium and information accessibility steadily increasing, the mainstream media is becoming less relevant. Historically, there …

Harm reduction and drug policy reform go hand in hand. We hear the two terms used interchangeably, which makes sense as most drug policy reforms are grounded and associated with …

Over the last few months, there’s been a push from the government to ‘crack down’ on antisocial behaviour and stamp out illegal drugs in communities. Why are the conservatives cracking …

By Katya Kowalski, with additional reporting by Sarah Sinclair, Cannabis Health  The UK’s medical cannabis industry has at times felt like a broken record. Once the hype of the law …

There’s been a significant amount of overinflation and hype surrounding the CBD industry in the UK. Has the sector begun to stagnate? What should the CBD sector’s next move be? …

Access the full report here: Volteface Report: Known Unknowns Plain Text version: Volteface Report: Known Unknowns Plain Text  Over the last year Volteface has been researching the barriers and hesitations …

  Volteface is today launching a new initiative that aims to improve the medical cannabis industry by giving patients a voice, and the chance to shape their future care.  Partnering …